393 related articles for article (PubMed ID: 9135048)
21. Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat.
Moore AE; Cicchetti F; Hennen J; Isacson O
Exp Neurol; 2001 Dec; 172(2):363-76. PubMed ID: 11716560
[TBL] [Abstract][Full Text] [Related]
22. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
Lapchak PA; Miller PJ; Collins F; Jiao S
Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
[TBL] [Abstract][Full Text] [Related]
23. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease.
Shear DA; Dong J; Gundy CD; Haik-Creguer KL; Dunbar GL
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1217-40. PubMed ID: 9829299
[TBL] [Abstract][Full Text] [Related]
24. Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test.
Borlongan CV; Randall TS; Cahill DW; Sanberg PR
Brain Res; 1995 Apr; 676(1):231-4. PubMed ID: 7796175
[TBL] [Abstract][Full Text] [Related]
25. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
Paul ML; Currie RW; Robertson HA
Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
[TBL] [Abstract][Full Text] [Related]
26. Paradoxical increase in 3-nitropropionic acid neurotoxicity by alpha-phenyl-tert-butyl-nitrone, a spin-trapping agent.
Lan MY; Chang YY; Chen SS; Wu HS; Chen WH; Liu JS
Chang Gung Med J; 2005 Feb; 28(2):77-84. PubMed ID: 15880982
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system.
Barnéoud P; Descombris E; Aubin N; Abrous DN
Eur J Neurosci; 2000 Jan; 12(1):322-36. PubMed ID: 10651887
[TBL] [Abstract][Full Text] [Related]
28. 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum.
Vis JC; Verbeek MM; De Waal RM; Ten Donkelaar HJ; Kremer HP
Neuropathol Appl Neurobiol; 1999 Dec; 25(6):513-21. PubMed ID: 10632901
[TBL] [Abstract][Full Text] [Related]
29. Excitotoxic lesions of the pedunculopontine tegmental nucleus of the rat. II. Examination of eating and drinking, rotation, and reaching and grasping following unilateral ibotenate or quinolinate lesions.
Dunbar JS; Hitchcock K; Latimer M; Rugg EL; Ward N; Winn P
Brain Res; 1992 Sep; 589(2):194-206. PubMed ID: 1356593
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of neurotrophin-4/5 and transforming growth factor-alpha on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid.
Alexi T; Venero JL; Hefti F
Neuroscience; 1997 May; 78(1):73-86. PubMed ID: 9135090
[TBL] [Abstract][Full Text] [Related]
31. Behavioral/neurophysiological investigation of effects of combining a quinolinic acid entopeduncular lesion with a fetal mesencephalic tissue transplant in striatum of the 6-OHDA hemilesioned rat.
Olds ME; Jacques DB; Kpoyov O
Synapse; 2003 Jul; 49(1):1-11. PubMed ID: 12710010
[TBL] [Abstract][Full Text] [Related]
32. The 6-OHDA mouse model of Parkinson's disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions.
Bagga V; Dunnett SB; Fricker RA
Behav Brain Res; 2015 Jul; 288():107-17. PubMed ID: 25841616
[TBL] [Abstract][Full Text] [Related]
33. Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity.
Schulz JB; Henshaw DR; MacGarvey U; Beal MF
Neurochem Int; 1996 Aug; 29(2):167-71. PubMed ID: 8837046
[TBL] [Abstract][Full Text] [Related]
34. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration.
Wenning GK; Granata R; Laboyrie PM; Quinn NP; Jenner P; Marsden CD
Mov Disord; 1996 Sep; 11(5):522-32. PubMed ID: 8866493
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases.
Schulz JB; Matthews RT; Henshaw DR; Beal MF
Neuroscience; 1996 Apr; 71(4):1043-8. PubMed ID: 8684608
[TBL] [Abstract][Full Text] [Related]
36. Dopamine-rich grafts in the neostriatum and/or nucleus accumbens: effects on drug-induced behaviours and skilled paw-reaching.
Abrous DN; Shaltot AR; Torres EM; Dunnett SB
Neuroscience; 1993 Mar; 53(1):187-97. PubMed ID: 8469306
[TBL] [Abstract][Full Text] [Related]
37. Comparison between normal developing striatum and developing striatal grafts using drug-induced Fos expression and neuron-specific enolase immunohistochemistry.
Labandeira-Garcia JL; Tobio JP; Guerra MJ
Neuroscience; 1994 May; 60(2):399-415. PubMed ID: 7915411
[TBL] [Abstract][Full Text] [Related]
38. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms.
Kumar P; Padi SS; Naidu PS; Kumar A
Behav Pharmacol; 2006 Sep; 17(5-6):485-92. PubMed ID: 16940769
[TBL] [Abstract][Full Text] [Related]
39. Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.
Labandeira-Garcia JL; Rozas G; Lopez-Martin E; Liste I; Guerra MJ
Exp Brain Res; 1996 Feb; 108(1):69-84. PubMed ID: 8721156
[TBL] [Abstract][Full Text] [Related]
40. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
Pollack AE; Turgeon SM; Fink JS
Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
